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Abstract
The p400 E1A-associated protein, which mediates H2A.Z incorporation at specific promoters, plays a major role in cell fate
decisions: it promotes cell cycle progression and inhibits induction of apoptosis or senescence. Here, we show that p400
expression is required for the correct control of ROS metabolism. Depletion of p400 indeed increases intracellular ROS levels
and causes the appearance of DNA damage, indicating that p400 maintains oxidative stress below a threshold at which
DNA damages occur. Suppression of the DNA damage response using a siRNA against ATM inhibits the effects of p400 on
cell cycle progression, apoptosis, or senescence, demonstrating the importance of ATM–dependent DDR pathways in cell
fates control by p400. Finally, we show that these effects of p400 are dependent on direct transcriptional regulation of
specific promoters and may also involve a positive feedback loop between oxidative stress and DNA breaks since we found
that persistent DNA breaks are sufficient to increase ROS levels. Altogether, our results uncover an unexpected link between
p400 and ROS metabolism and allow deciphering the molecular mechanisms largely responsible for cell proliferation control
by p400.
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Introduction
Cell fate decisions largely rely on the activation or the repression
of specific genetic programs. Proteins, which regulate these genetic
programs, are involved in the accurate control of cell fate. Among
these proteins, chromatin modifying-enzymes are proposed to play
a special role because they can set up epigenetic imprints in
chromatin and thus mediate long term and transmissible effects on
chromatin function. In mammals, one such protein is the p400
ATPase which is an ATPase of the SWI/SNF family conserved
from yeast to human (it is called SWR1 in yeast and Domino in
drosophila) [1–3]. It belongs to a multimolecular complex, which
contains other enzymes such as the helicases Tip49a and Tip49b
and, at least in mammals and in drosophila, the histone acetyl
transferase Tip60 [1,4–6]. p400 can mediate exchange of histone
H2A variants, such as H2A.Z in yeast and mammals and H2Av
(which is a drosophila-specific variant related to both H2A.Z and
H2A.X) in drosophila [4–8]. Through this activity, p400
participates in various processes such as DNA double strand
breaks (DSBs) repair and transcription: in drosophila, Domino
exchanges phosphorylated H2Av by unphosphorylated H2Av
following completion of DNA repair, leading to the suppression of
DNA DSB signalling [5]. Transcriptional regulation by p400
largely relies on H2A.Z incorporation at specific promoters [9].
H2A.Z incorporation can lead both to positive or negative
outcome for transcription: whereas removal of H2A.Z is often
required for transcription to occur, H2A.Z can also ‘‘poise’’ genes
for activation, preventing the propagation of neighbouring
repressive heterochromatin [10]. In agreement with this dual
effect of H2A.Z in transcription, p400 mediates transcriptional
repression of the p21 gene in the absence of DNA damage [11,12]
but it is also required for transcriptional activation of estrogen-
responsive genes upon hormone treatment [13], both effects being
mediated through H2A.Z incorporation [7].
Many results underline the role of p400 and p400-associated
proteins in cell fate decisions control. First, p400 was characterized
as a protein associated with the viral transforming protein E1A
from adenovirus [1]. Moreover, association with p400 was found
to be required for E1A to promote cell transformation as well as
apoptosis [1,14], indicating that p400 is important for E1A-
mediated cell proliferation and cell transformation control. p400
prevents cell cycle arrest in human osteosarcoma-derived cells
[12], inhibits apoptosis in colon carcinoma-derived cells [15] and
blocks senescence induction in non transformed human fibroblasts
[11] or mouse embryonic fibroblasts [16]. Also, depletion of p400
or of associated proteins (such as Tip60) results in a decrease cell
proliferation rate of embryonic stem cells [17]. Altogether, these
data point to a critical role of p400 in allowing cell proliferation.
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The function of p400 in preventing cell cycle arrest or
senescence is proposed to be mediated through the direct
transcriptional regulation of p21 expression by localized H2A.Z
incorporation [7]. However, we show here that p400 depletion can
induce oxidative stress suggesting that it may also indirectly
activate p21 expression through the activation of DNA damage
pathways. By inhibiting these pathways, we show that this indirect
mechanism largely account for p21 regulation by p400 as well as
for downstream control of cell fate (such as senescence, cell cycle
progression or apoptosis). Altogether, our results allow us to
decipher the molecular mechanism which accounts for most of the
effects of p400 on cell proliferation.
Results
p400 knockdown induces ROS accumulation
In order to identify genes regulated by p400, we performed a
genome wide analysis of genes affected upon p400 knockdown. We
transfected U2OS osteosarcoma cells in duplicates with two control
siRNAs and two previously described siRNAs directed against p400
[12]. Silencing efficiency was checked by real time PCR and western
blotting (Figure S1A and S1B). Moreover, the p21 mRNA was
induced by p400 depletion (Figure S3B), as already described [12].
Forty-eight hours following transfection, we prepared total RNA that
we analysed on Affymetrix gene microarrays containing 19,734 gene
probe sets. We then compared gene expression upon transfection of
each anti-p400 siRNA against each control siRNA independently.
After normalization, statistical analysis and thresholding (see
Materials and Methods), we considered genes as regulated by
p400 when they are similarly affected in three out of the four
conditions (p400-1 vs Ctrl-1, p400-2 vs Ctrl-1, p400-1 vs Ctrl-2 and
p400-2 vs Ctrl-2). 878 genes were identified and, as expected, the
p400 mRNA was found decreased upon p400 siRNA transfection
whereas the p21 mRNA was found activated. The complete list of
modified genes, sorted by the mean of fold change, is shown in
Figure S2. In addition, we validated our microarrays results by
analysing several genes by real time PCR (Figure S3). A Gene
Ontology (GO) analysis (see Figure 1 for the eight top singular
annotations) indicates that p400 mainly regulates genes linked to cell
proliferation (the first three singular annotations are composed of
genes involved in cell cycle, cell division andmitosis). Such regulation
is expected and is likely to be indirect, since p400 knockdown affects
cell cycle progression [12]. The next singular annotation represents
genes involved in the oxido-reduction balance, suggesting a link
between p400 and the control of oxidative stress.
To test this hypothesis, we directly measured the intracellular
levels of ROS (Reactive Oxygen Species, a major intracellular
inducer of oxidative stress) using fluorescent probes by flow
cytometry upon siRNA transfection. We found that the knock-
down of p400 leads to an increase of ROS levels (measured by
calculating the mean fluorescence from 25,000 cells) detectable
48 hours and 72 hours following siRNA transfection (Figure 2A).
This increase is similar to what is observed in cells treated with
H2O2, an oxidant molecule (Figure S4A), or in cells presenting
mutations in the succinate dehydrogenase enzyme, a protein
directly involved in the control of the respiratory chain in
mitochondria [18]. Moreover, this increase was also observed
using 2 other independent p400 siRNAs (Figure 2B, see Figure
S1B for RT-PCR monitoring p400 expression silencing), ruling
out the possibility of any off-target effects. Thus, altogether, these
results indicate that p400 is required to decrease ROS levels in
U2OS cells. To confirm the importance of p400 in controlling
ROS levels, we used MEFs originating from mice in which the
p400 gene has been genetically targeted [19]. We prepared wild
type and heterozygous MEFs. Both MEFs grow at identical rates
and presented similar basal ROS levels (data not shown). We next
treated these MEFs with H2O2 to analyse their response to an
oxidative stress increase. We found that the increase in ROS levels
following 15 min H2O2 treatment was similar in both genotypes
(Figure 2C). To test their ability to cope with this ROS increase,
we washed H2O2 and we analysed the decrease in ROS levels. In
wild type cells, the decrease in ROS levels was very rapid since
they went down to basal levels in less than two hours (Figure 2C).
In MEFs in which one allele of p400 had been targeted, the
decrease was slower and ROS levels was still largely above basal
levels two hours following H2O2 removal (Figure 2C). Thus, the
loss of one p400 allele leads to a defective management of ROS
levels following a burst of oxidative stress, demonstrating that the
role of p400 in controlling ROS levels is not limited to human cells
neither to tumoral cells. Taken together, Figure 2A–2C data
indicate that normal p400 expression is required to control ROS
levels.
p400 prevents oxidative stress-induced DNA damage
and DNA damage signalling
Deregulated ROS production can lead to DNA damage. We
then reasoned that p400 could maintain ROS levels below a
threshold which could be detrimental to DNA integrity. To test
this possibility, we investigated whether knockdown of p400 in
U2OS cells leads to the generation of DNA damage. We
performed a neutral comet assay, which directly reveals the
amount of DNA strand breaks (single and double strand breaks)
and alkali-labile sites. We found that the number of cells with
detectable comet tails (thus, with detectable DNA breaks) was
increased upon p400 knockdown (Figure 2D for typical cells and
Figure 2E for the quantification; see Figure S5 for more detailed
distribution of comet tail moments). Importantly, very similar
results were obtained using another independent p400 siRNA
(Figure S6). We thus conclude from this experiment that p400
expression is required for genetic integrity and that p400 prevents
both increased ROS production and accumulation of DNA
damage.
In order to test whether DNA damage induced by the absence
of p400 are due to oxidative stress, we used N-Acetyl Cysteine
(NAC), a widely used anti-oxidant reagent. As expected, NAC
treatment efficiently reversed the increase in ROS levels induced
by p400 knockdown (Figure 3A). Importantly, NAC treatment also
reversed the increase in comet tail moments upon p400
knockdown (Figure 3B, see also Figure S6 with an independent
p400 siRNA). Thus, these data indicate that p400 prevents
oxidative stress–induced DNA damage.
Author Summary
External or internal causes can lead to the generation of
oxidative stress in mammalian cells. This oxidative stress is
detrimental to cell life since it can induce protein damages
or, even worse, DNA damages. Thus, cells have to control
strictly oxidative stress levels. In this manuscript, we show
that the p400 ATPase, a chaperone of specific histone H2A
variants, is important for this control in mammals and
therefore prevents DNA damage induction. Moreover, we
demonstrate that the known roles of p400 in cell
proliferation are dependent upon its effect on oxidative
stress. Finally, we identify the mechanisms by which p400
modulates oxidative stress levels. Altogether, our study
uncovers a new role of mammalian p400 and demon-
strates its functional importance.
p400 and ROS Homeostasis
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We next tested whether p400-induced DNA damage can lead to
the activation of a DNA Damage Response (DDR) and then to a
cellular response. We found that knockdown of p400 in U2OS cells
is sufficient to induce a significant increase of cells harbouring
cH2AX foci (Figure 3C and 3D), a widely used marker of DNA
damage signalling. It also leads to an increase in autophosphoryla-
tion of the sensor kinase ATM (reflecting ATM activation),
measured either by immunofluorescence or by western blot
(Figure 4A and 4B). In addition, phosphorylation of downstream
substrates of ATM, such as the p53 tumour suppressor, was induced
(Figure 4B). Thus, p400 knockdown results in the activation of
ATM-dependent DNA damage response pathways. Strikingly,
NAC treatment partially reversed the appearance of cH2AX foci
(Figure 3C and 3D) thereby indicating that DNA damage signalling
induced by p400 siRNA is mediated through increased oxidative
stress. Thus, altogether, Figure 3 and Figure 4 results indicate that
p400 prevents the induction of DNA damage and of ATM-
dependent DNA damage signalling by oxidative stress.
Figure 1. Gene singular annotation of DNA microarrays data. U2OS cells were independently transfected using two controls and two
different p400-targetting siRNAs. Total RNA was then prepared 48 h later and submitted to reverse transcription, cDNA control quality and
hybridization on Affymetrix DNA microarrays (GeneChip Human Gene 1.0 ST Array). Following quantification of two independent experiments,
normalization and statistical analysis was done using GeneSpring GX software (Agilent Technologies). Qualified genes were those found regulated, in
the same way, in at least 3 out of the four comparisons (p400-targeting siRNAs versus controls) and with a fold change at least equal at 1.25.
Presented gene annotation discovery was done using GeneCoDis2 online software.
doi:10.1371/journal.pgen.1000983.g001
p400 and ROS Homeostasis
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p400 allows cell cycle progression by preventing the
activation of ATM–dependent DDR pathways
We next intended to investigate the contribution of these ATM-
dependent DNA damage response pathways to cell proliferation
control by p400. As already reported [11,12], we found that p400
knockdown induces the activation of the gene encoding the p21
cell cycle-dependent kinase inhibitor (Figure 4C), as well as the
concomitant accumulation of cells in the G1 phase of the cell cycle
(Figure 4D). Importantly, the two fold induction of p21 mRNA
induction, as well as the extent of cell cycle arrest we observed
Figure 2. p400 depletion leads to ROS accumulation and DNA damage induction. (A) U2OS cells were transfected using the indicated
siRNA. 48 and 72 h following transfection (as indicated), cells were collected and ROS levels were measured by flow cytometry. The mean and
standard deviation (SD) from 3 independent experiments are shown (after standardisation relative to 1 for cells transfected with the control siRNA).
(B) U2OS cells were transfected using the indicated siRNA and 48 h following transfection, cells were collected and ROS levels were measured by flow
cytometry. The mean and SD from 3 independent experiments are shown (after standardisation relative to 1 for cells transfected with the control
siRNA). (C) MEFs derived from heterozygous embryos in which one p400 allele was targeted (p400Mut/+)[19] or from control wild type embryos (wt)
were treated or not, as indicated, with 10 mM of H2O2 for 15 min. H2O2 was washed out and cells were collected after the indicated time. ROS levels
were measured by flow cytometry. The ROS levels increase was calculated by subtracting ROS levels in untreated cells (measured in parallel). The
mean and SD from 2 to 3 independent experiments are shown (after standardisation relative to 1 for untreated cells). (D,E) U2OS cells were
transfected using the indicated siRNA and 48 hours following transfection, cells were subjected to comet assay. Representative cells are shown in (D).
The mean and SD of the proportion of comet-positive cells (tail moment .5) from three independent experiments are shown in (E) (calculated
relative to 100 for cells transfected with the p400-1 siRNA).
doi:10.1371/journal.pgen.1000983.g002
p400 and ROS Homeostasis
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here, is within the range of what has been found previously in
U2OS cells by others and us [11,12]. p400-mediated repression of
the p21 promoter was proposed to be direct and to rely on the
targeted incorporation of H2A.Z on the p21 promoter [7].
However, it may also be an indirect consequence of ATM-
dependent DDR pathways repression by p400 since the p21
promoter is a direct target of the DNA damage-activated p53
tumour suppressor. To assess the relative contribution of these two
mechanisms (direct repression through H2A.Z incorporation (as
demonstrated by [7]) and control of ATM-dependent DNA
damage pathways (as we observed here)), we intended to inhibit
these DNA damage pathways using a siRNA directed against
ATM. Transfection of the ATM siRNA efficiently inhibits ATM
expression and does not affect silencing of p400 by the p400
siRNA (Figure S1A). The ATM siRNA by itself does induce only a
slight decrease, if any, of p21 mRNA expression (Figure 4C).
However, it decreases the activation of p21 mRNA and protein
expression induced by p400 depletion (Figure 4C). Moreover, it
partially reversed the concomitant cell cycle arrest (Figure 4D).
Importantly, activation of p21 mRNA (Figure 4E) and cell cycle
arrest (Figure 4F) induced by Nutlin-3, an inhibitor of the p53/
Mdm2 interaction [20], is not affected by ATM knockdown,
indicating that ATM is not generally required for the p53-
dependent activation of p21 mRNA expression and cell cycle
arrest and then, that the effect of ATM is upstream of p53
activation. Thus, taken together, these data indicate that p400
represses p21 expression, at least in part, through the control of
DNA damage pathways. Note that the residual activation of p21
mRNA and G1 accumulation induced by p400 depletion in the
presence of ATM siRNA, is probably due to directs effects of p400
on the p21 promoter [7].
p400 controls cell fate through the modulation of DDR
pathways
Strikingly, other proposed roles of p400 in cell proliferation
(repressor of apoptosis in HCT116 cells [15] and repressor of
senescence in IMR90 cells [11]) could also be dependent on its
ability to modulate ATM-dependent DNA damage pathways.
First, we checked whether p400 also controls ATM-dependent
DDR pathways in these cells by transfecting them with a p400
siRNA, which decreased p400 mRNA or protein levels as
expected (Figure S7). We observed by immunofluorescence
staining that p400 knockdown induces ATM phosphorylation
both in IMR90 cells (Figure 5A) and HCT116 cells (Figure 5B).
Thus the ability of p400 to prevent activation of DDR pathways is
not restricted to U2OS cells.
Figure 3. p400 prevents ROS–induced DNA damage. (A) U2OS cells were transfected using the indicated siRNA and treated with NAC (10 mM).
48 h later, cells were collected and ROS levels were measured by flow cytometry. The mean from 2 independent experiments is shown (after
standardisation relative to 1 for cells transfected with the control siRNA and untreated). (B) U2OS cells were transfected using the indicated siRNA and
treated with NAC (10 mM) 24 h later. 48 h following transfection, cells were subjected to a comet assay. The mean and SD of the proportion of
comet-positive cells (tail moment.5) from three independent experiments are shown (calculated relative to 100 for cells transfected with the p400-1
siRNA and not treated). (C,D) Same as in (A) except that cells were fixed and subjected to DAPI staining and an immunofluorescence analysis using
anti-cH2AX antibodies. Representative fields are shown in (C) and quantification using ImageJ software is shown in (D) (mean and SD from 3
independent experiments are shown (after standardisation relative to 100 for cells transfected with the p400 siRNA and untreated)).
doi:10.1371/journal.pgen.1000983.g003
p400 and ROS Homeostasis
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Figure 4. p400 depletion leads to the induction of a DNA damage response. (A) U2OS cells were transfected using the indicated siRNA. 48 h
after transfection, cells were fixed and subjected to DAPI staining and an immunofluorescence analysis using anti-phosphoATM antibodies.
Representative fields are shown on the left and quantification using ImageJ software on the right (the mean and SD from 3 independent experiments
are shown (after standardisation relative to 1 for cells transfected with the control siRNA)). (B) Same as in (A), except that total cell extracts were
prepared and analysed by western blot using anti-ATM, anti-Phospho-ATM, anti-Phospho-p53 and anti-HDAC1/2 (as a loading control) antibodies.
Note that the asterisk indicates non-specific bands in the Phospho-p53 panel. (C) U2OS cells were transfected using the indicated siRNA alone or in
combination as indicated. The total amount of siRNA in the transfection was kept constant using the control siRNA. 48 h later, total cell extracts were
prepared and analysed by western blot using anti-p21 and anti-b-actin (as a loading control) antibodies (upper panel). Total RNA were also prepared,
reverse transcribed and cDNA were then analysed for p21 and GAPDH expression by Q-PCR. The amount of p21 cDNA was divided by the amount of
GAPDH cDNA and calculated relative to 1 for cells transfected using the control siRNA (lower panel). The mean and SD from 5 independent
experiments are shown. (D) Same as in (C), except that cells were harvested and analysed for cell cycle distribution by flow cytometry. The proportion
of G0/G1, S and G2/M cells in each condition were quantified relative to 1 for cells transfected by the control siRNA. The mean and SD from 3
independent experiments are shown. (E) U2OS were transfected using the indicated siRNA and treated with Nutlin-3. 48 h later, total RNA were
prepared, reverse transcribed. cDNAs were then analysed for p21 and GAPDH expression by Q-PCR. The amount of p21 cDNA was divided by the
amount of GAPDH cDNA and calculated relative to 1 for cells transfected using the control siRNA and treated with nutlin. The mean from two
independent experiments is shown. (F) Same as in (E), except that cells were harvested and analysed for cell cycle distribution by flow cytometry as
described in (D). The mean from two independent experiments is shown.
doi:10.1371/journal.pgen.1000983.g004
p400 and ROS Homeostasis
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We next investigated the involvement of ATM-dependent DDR
pathways activation in cell fate control by p400. To this aim, we co-
transfected cells with the siRNAs against p400 and ATM in HCT116
and IMR90 cells. In these two cell types, transfection of the ATM
siRNA efficiently inhibits ATM expression and does not affect
silencing of p400 by the p400 siRNA (Figure S7). As already
demonstrated [11], transfection of p400 siRNA leads to senescence of
IMR90 cells, as observed by the appearance of the so-called SAHF
(Senescence-Associated Heterochromatin Foci) (Figure 5C), the
induction of Senescence–Associated b-Galactosidase activity
(Figure 5D) and induction of p16 mRNA expression (Figure 5E).
Depletion of ATM does not have any effect by itself on senescence
induction. However, depletion of ATM completely reverses the
induction of senescence by the transfection of p400 siRNA (Figure 5C–
5E), indicating that ATM expression is required for p400 knockdown
to induce senescence. Similarly, we found that ATM expression is also
required for p400 knock-down-induced apoptosis in HCT116 cells
(Figure 5F). Thus taken together, these data indicate that cell fate
control by p400 is largely dependent on its ability to prevent activation
of ATM-dependent DNA damage pathways.
Figure 5. The ATM–dependent DDR is required for senescence and apoptosis induced by p400. (A,B) IMR 90 cells (A) or HCT 116 cells (B)
were transfected using the indicated siRNA. 48 h following transfection, cells were fixed and analysed by immunofluorescence using an anti-
phosphoATM antibody. PhosphoATM positive cells were quantified using ImageJ software and calculated relative to 1 for cells transfected with the
control siRNA. The mean and SD from three independent experiments are shown. (C) IMR 90 cells were transfected with the indicated siRNA alone or
in combination. The total amount of siRNA in the transfection was kept constant using the control siRNA. 7 days following transfection, cells were
collected and subjected to DAPI staining to analyse SAHF formation. (D) Same as in (C), except that Senescence associated b-galactosidase activity
was measured and calculated relative to 1 for cells transfected with the control siRNA alone. The mean and SD from three independent experiments
are shown. (E) Same as in (C) except that mRNA were extracted and reverse transcribed. cDNAs were then analysed by Q-PCR for p16 and GAPDH
mRNA expression. The amount of p16 cDNA was divided by the amount of GAPDH cDNA and calculated relative to 1 for cells transfected using the
control siRNA alone. The mean and SD from three independent experiments are shown. (F) HCT116 cells were transfected with the indicated siRNA
alone or in combination. The total amount of siRNA in the transfection was kept constant using the control siRNA. 48 h following transfection,
apoptosis induction was measured by flow cytometry and the percentage of apoptotic cells was calculated relative to 1 for cells transfected with the
control siRNA. The mean and SD from three independent experiments are shown.
doi:10.1371/journal.pgen.1000983.g005
p400 and ROS Homeostasis
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DNA double-strand breaks induction results in ROS
increase
We next addressed the mechanism by which p400 knockdown
leads to ROS production. Strikingly more and more evidence
suggests that persistent DNA damage (due for example to defective
DNA repair pathways) induces an oxidative stress [21–24]. Since
p400 depleted cells present an increase in DNA breaks (see
Figure 2D and 2E), we tested whether this increase in DNA
damage could participate in ROS production. To test whether
DNA breaks can induce ROS production in U2OS cells, we used
a cell line derived from U2OS cells in which we can induce the
nuclear localisation of the AsiS1 restriction enzyme by 4-hydroxy-
tamoxifen (OHTam) treatment. When localized in the nucleus,
this restriction enzyme generates a large number (about 200) of
pure double strand breaks (DSBs) [25] (in contrast to more widely
used methods, such as ionizing radiations, which directly produce
free radicals). OHTam treatment generated nuclear accumulation
of the restriction enzyme and efficiently induced DNA DSBs, as
indicated by the appearance of cH2AX foci (Figure 6A). DNA
breaks induction is very rapid since increased cH2AX staining can
be detected as early as 15 min following OHTam addition (data
not shown). Moreover, very high levels of cH2AX staining are still
observed 48 hours following OHTam addition demonstrating that
the DNA DSBs persist up to 48 hours of treatment (most likely
because restriction sites are permanently repaired and re-cleaved)
(Figure 6A). We then treated, or not, these cells with OHTam for 4
or 48 hours and we measured ROS levels. Whereas no change
could be detected 4 hours following OHTam, ROS levels were
strongly increased after 48 hours of OHTam treatment, reaching
a level similar to the one measured 48 hours after p400-targeting
siRNA transfection (Figure 6B). Importantly, no increase in ROS
production could be observed in parental U2OS cells treated with
OHTam (data not shown), indicating that ROS production is
indeed due to the generation of DSBs by the restriction enzyme.
These results indicate that in U2OS, whereas the presence of
DNA DSBs per se is not able to induce a detectable increase in
ROS levels (as indicated by the results obtained 4 hours following
OHTam treatment), their persistence for up to 48 hours is
sufficient to induce such an increase. Thus, the presence of
persistent DNA damage in cells depleted by p400 could participate
in the increase in oxidative stress.
p400 directly regulates genes important for the control
of oxidative stress
However, such a mechanism does not fully explain our results
since we found that DNA damage induction by p400 is partially
blocked by anti oxidant treatment (indicating that DNA breaks
induction is, at least partly, a consequence and not a cause of
oxidative stress increase). Moreover, we found that p400
expression is important to restore normal ROS levels upon
exogenous oxidative stress increase at time points (4 hours, see
Figure 2C) at which DNA damages do not increase ROS levels
(see Figure 6B). Thus, we investigate whether some of the effects of
p400 on ROS levels control could be transcriptional. Specific
inspection of the microarrays results indicates that p400 indeed
regulates many genes whose products are known to be involved in
the control of ROS levels, in such way that it could favour an
increase in ROS levels (such as Hsp70 [26–28], FANCA [29,30] or
Lamin B1 [31]). To investigate the importance of transcriptional
control in the effects of p400 on ROS levels, we focused on Hsp70
and FANCA. Indeed, knocking-down Hsp70 expression induces
oxidative stress in many cell type, and oxidative stress manage-
ment is defective in cells from the Fanconi anemia group A
[29,30]. Moreover, we observed, in our microarrays analyses, that
FANCA mRNA as well as two mRNAs coding for Hsp70 protein
(Hspa1a and Hspa1b) (collectively referred as ‘‘Hsp70’’ thereafter
since they encode identical proteins [32]) are decreased upon p400
knockdown (Figure S2). We first checked whether Hsp70 and
FANCA are bona fide target genes of p400. We transfected U2OS
cells with two independent p400 siRNAs and analysed Hsp70 and
FANCA mRNA expression by RT-QPCR. We confirmed that
Hsp70 and FANCA mRNA levels are decreased in cells
transfected by p400 siRNA, indicating that p400 positively
regulates their expression (Figure S3C). Moreover, we also found
that p400 knockdown decreases Hsp70 and FANCA protein
expression (Figure 7A). We next tested whether these two genes
can be direct transcriptional targets of p400: indeed, p400 is
known to favour transcription through binding to specific
promoters, such as some controlling genes involved in mainte-
nance of embryonic stem cells [17] or estrogen-responsive genes
[13]. Thus, to test whether p400 can directly regulate the
promoter of Hspa1a (a gene coding for Hsp70 protein) and of
FANCA, we performed Chromatin ImmunoPrecipitation (ChIP)
experiments with p400 antibodies using chromatin from U2OS
cells. As expected, we could detect p400 binding to the p21
promoter (a known direct target of p400 [11]) (Figure 7B). This
binding is specific, since an unrelated sequence derived from the
ribosomal phosphoprotein P0 promoter was only marginally
enriched in the p400 immunoprecipitates (IP). Strikingly, we
found that sequences derived from the Hspa1a gene promoter and
from the FANCA promoter are also enriched in the p400 IP (with
an efficiency comparable to the p21 promoter) (Figure 7B),
indicating that p400 physically binds to these two promoters.
Taken together, these results indicate that the Hspa1a and FANCA
promoters are directly regulated by p400.
Direct regulation of promoter activity by p400 often involves
incorporation of the H2A.Z variant. To test the involvement of
H2A.Z incorporation in p400-mediated regulation of these
promoters, we depleted H2A.Z expression using a specific siRNA
(see Figure S1C for RT-PCR and western blot showing the
efficiency of H2A.Z depletion). We found that this depletion leads
to a decrease in Hsp70 mRNA expression (Figure 7C) but not of
FANCA mRNA expression (Figure 7D), suggesting that p400
regulates these two promoters by independent mechanisms.
p400-regulation of Hsp70 and FANCA is important for
ROS control
We next tested whether transcriptional regulation can be
important for p400 to control intracellular ROS levels. To this
aim, we transfected together with the p400 siRNA, an expression
vector for Hsp70 and FANCA to prevent the decrease of their
mRNA. Such an experiment is feasible since transfection efficiency
for plasmids routinely reached from 50 to 80% in U2OS cells (data
not shown). In addition, RT-PCR measurement of mRNA levels
indicated that, in cells transfected by the expression vector, the
p400 siRNA efficiency was unchanged (data not shown). We next
measured ROS levels 48 hours following transfection. We found
that ectopic expression of Hsp70 or FANCA have, by themselves,
no effect on ROS levels in U2OS cells (Figure 8A). However, they
significantly inhibited the increase in ROS levels induced by p400
knockdown (Student t-test p,105 on three independent experi-
ments). This result indicates that, if the down regulation of Hsp70
or FANCA is prevented, p400 siRNA transfection induces ROS
production less efficiently. Thus, regulation of Hsp70 and FANCA
expression is required for p400 to control ROS production.
Finally, we transfected U2OS cells with siRNAs directed against
Hsp70 and FANCA to test whether we can recapitulate the effects
p400 and ROS Homeostasis
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Figure 6. Persistent DNA breaks are sufficient to induce oxidative stress. (A) U2OS HA-AsiSI-ER cells were treated with OHTam for 4 h or
48 hours, or not, as indicated. Cells were then fixed and subjected to DAPI staining and immunofluorescence using anti-HA (top panels) and anti-
cH2AX (bottom panel) antibodies. (B) Same as in (A) except that ROS levels were measured by flow cytometry. The mean and SD from 3 independent
experiments are shown (after standardisation relative to 1 for cells untreated with OHTam).
doi:10.1371/journal.pgen.1000983.g006
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Figure 7. Hsp70 and FANCA are direct target genes of p400. (A) U2OS cells were transfected using the indicated siRNA. 48 h following
transfection, total cell extracts were prepared and analysed by western blot using anti-FANCA, anti-Hsp70 and anti-GAPDH (as a loading control)
antibodies. (B) U2OS cells were subjected to a ChIP experiment using p400 antibodies or without antibody as indicated. The amounts of p21,
Phosphoprotein P0, Hspa1a and FANCA promoters in the immunoprecipitates and in the inputs were measured by Q-PCR. ChIP efficiency (% of input
DNA) was calculated relative to 1 for the amount of p21 promoter immunoprecipitated by the p400 antibody. The mean and SD from three
independent experiments are plotted. (C) U2OS cells were transfected using the indicated siRNA. 48 h following transfection, cells were harvested
and total RNA was prepared and reverse transcribed. cDNAs were then analysed for Hsp70 and GAPDH expression by Q-PCR. The amount of Hsp70
cDNA was divided by the amount of GAPDH cDNA and calculated relative to 1 for cells transfected using the control siRNA. The mean and SD from
three independent experiments are shown. (D) Same as in (C) except that cDNA were analysed for FANCA and GAPDH expression.
doi:10.1371/journal.pgen.1000983.g007
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Figure 8. Transcriptional regulation of Hsp70 is involved in ROS controls by p400. (A) U2OS cells were transfected using the indicated
siRNA and Hsp70 or FANCA expression vector (1.5 mg). Total amount of DNA in the transfection was kept constant using the corresponding empty
vector. 48 h later, cells were collected and ROS levels were measured by flow cytometry and calculated relative to 1 for cells transfected by the
control siRNA and empty vector. The mean and SD from three independent experiments are shown. The two stars (**) indicate a p value below 105
(Student t-test). B) U2OS cells were transfected using the indicated siRNA and 48 h following transfection, cells were collected and ROS levels were
measured by flow cytometry. The mean and SD from 3 independent experiments are shown (after standardisation relative to 1 for cells transfected
with the control siRNA). (C) Our model of cell proliferation control by p400: p400 prevents oxidative stress through transcriptional regulation of
specific promoters. Oxidative stress in turn induces persistent DNA damage. These persistent DNA damages favour an additional oxidative stress
increase (‘‘positive feedback loop’’) and induce the activation of the DNA damage response pathways, resulting in a potent inhibition of cell
proliferation (through senescence, cell cycle arrest or apoptosis induction depending on the cell type). The dash line represents a putative role of
p400 in DNA repair (demonstrated in other species), which may contribute to the persistence of DNA damage.
doi:10.1371/journal.pgen.1000983.g008
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of the p400 siRNA on ROS production. Both siRNAs inhibited
their targets as shown by reverse transcription followed by Q-PCR
or western blotting experiments (Figure S1D and S1E). We next
measured their effects on ROS production and we found that,
whereas inhibition of Hsp70 has no effect by itself, transfection of
FANCA siRNA induces ROS accumulation (Figure 8B). Thus,
this result indicates that FANCA is certainly a critical target by
which p400 controls oxidative stress. In agreement with this
hypothesis, H2A.Z inhibition, which does not affect FANCA
expression (Figure 7D), does not induce any increase in ROS levels
(Figure S8). Defects in Hsp70 expression, although probably not
causal in oxidative stress induction, likely participates in the
defective response to oxidative stress in p400-depleted cells, since
activation of Hsp70 mRNA expression upon acute oxidative stress
in MEFs is abrogated upon loss of one p400 allele (Figure S9).
Taken together, these results indicate that the p400-mediated
control of ROS levels and cell proliferation is brought about, at
least in part, through the transcriptional regulation of specific
promoters, including the FANCA and Hsp70 promoters.
Discussion
p400 controls anti-oxidant pathways
In this manuscript, we first demonstrate that p400 plays a major
role in the control of ROS metabolism since a decrease of p400
level is sufficient to induce a ROS imbalance in U2OS cells.
Consequently, p400 expression is required to maintain ROS levels
below a threshold at which DNA damage are induced and the
DNA damage response (DDR) activated, and is important for
ROS homeostasis upon a burst of oxidative stress. We further
provide important information on the mechanism by which p400
exerts its anti-oxidant functions: First, we demonstrate that part of
the mechanism is transcriptional: indeed, some genes known to be
involved in the control of ROS levels are positively regulated by
p400 such as the genes coding for FANCA, Hsp70 and Lamin B1.
Moreover, the regulation of some of these proteins (FANCA and
Hsp70) is required for p400 to control ROS levels. It is likely that
the initial increase in ROS production upon p400 knock-down is
related to transcriptional defects in the expression of genes
involved in ROS metabolism such as FANCA. Indeed, p400
depletion leads to a decrease of FANCA levels to an extend at
which FANCA knockdown induces ROS (Figure 8B). It is thus
likely that the transcriptional defects, in the absence of p400, lead
to a deficiency in ROS removal and thus, due to the continuous
ROS production in living cells, in an increase in ROS levels and
oxidative stress. This increase will then lead to the induction of
DNA damage, since we found that DNA damages induction is
largely reversed by anti-oxidant treatment (Figure 3B).
Interestingly, our results suggest that the continuous presence of
DSBs per se is sufficient to induce ROS levels. The mechanism by
which persistent DSBs induces an oxidative stress is not known but
may be related to an elevated cellular metabolism to achieve DNA
repair. In agreement with this hypothesis, the existence of a link
between defects in DNA damage repair pathways and increased
ROS production is now becoming more and more clear [21–24].
Whatever the mechanism, the presence of persistent DSBs in the
absence of p400 may contribute to the observed increase in ROS
levels. These DSBs can be continuously created or may persist
because unrepaired. Strikingly, some p400 homologues in other
species (SWR1 in yeast and domino in drosophila) are known to
participate in DNA DSB repair. Moreover, we identify here
FANCA, a protein important for DNA repair, as a direct target
gene of p400. Finally, the GO analysis of our microarrays data of
p400 target genes has identified DNA repair as a major singular
annotation (See Figure 1). Therefore, it is tempting to speculate
that when p400 levels are low, unrepaired DSBs accumulate and
the persistence of these DNA breaks leads to ROS increase.
Such a mechanism cannot fully explain by itself our results
since, as noted above, antioxidant treatment largely reversed DNA
breaks (which would not be the case if DNA breaks would be
responsible for increased ROS production) and since p400Mut/+
MEFs exhibit a defective ROS response compared to wild type
MEFs at time points at which DNA breaks do not induce ROS
accumulation. Taken together, our results indicate that the
transcriptional defects in p400-depleted cells decrease ROS
metabolism leading to an initial ROS increase. This initial ROS
increase leads to the appearance of persistent DNA breaks, which
in turn favour continuous ROS production, which are incorrectly
managed in the absence of p400, resulting in the apparition of a
positive feedback loop inducing oxidative stress and the down-
stream cellular response (see our model in Figure 8C).
p400-mediated cell fate decisions largely rely on ROS
induction
p400 has been shown to play a critical role in cell fate decision
since it strongly favours cell proliferation by preventing senescence
induction [11], cell cycle arrest [12] and apoptosis induction [15].
Our data here indicate that inhibition of these anti-proliferative
states by p400 largely relies on the same molecular mechanism,
which is the control of intracellular ROS levels: upon p400
depletion, ROS levels are increased leading to endogenous
oxidative stress. This stress is high enough to induce DNA damage
and activation of the ATM-dependent DNA Damage Response.
Depending on the cell type, activation of this DDR following p400
knockdown will lead to induction of senescence (normal cells such
as IMR90 cells), cell cycle arrest or apoptosis (tumoral cells).
Importantly, although cell fate control by p400 was originally
shown to be largely dependent on the p53 tumour suppressor
[11,12], it is now clear that the effects of p400 on senescence or
apoptosis can also be p53-independent [15,16]: these latter effects
could be mediated by p53-independent DDR pathways. Also, our
findings could explain why p400 and its associated protein Tip60
have been described as antagonists [12,15]. Indeed, Tip60 is
largely required for DNA damage Response [33], at least in part
through ATM acetylation [34,35]: inactivation of Tip60 would
abolish any effects due to DDR activation following p400
depletion, as we described for p21 activation and accumulation
of cells in G1 [12] or for apoptosis induction [15].
Of note, Gevry et al. proposed that p400 represses p21
promoter through the targeted incorporation of H2A.Z variant
and that this repression is lost upon DNA damage induction [7].
Although we were able to confirm that p400 binds to the p21
promoter (Figure 7B) and that H2A.Z is enriched on the p21
promoter (data not shown), we show here that p400 can repress
p21 transcription indirectly: indeed, in U2OS cells, p400
knockdown induces activation of the ATM-dependent DDR
pathway and phosphorylation of p53. Moreover, induction of
ROS to levels comparable to those observed upon p400 depletion
is sufficient to induce activation of p21 mRNA expression (Figure
S4B). To distinguish between direct (through regulated H2A.Z
incorporation) or indirect (through the control of the DDR
pathways) repression of p21 promoter by p400, we inhibited the
DDR pathway and we found that we can partially relieve the
effects of p400 knockdown. Thus, the integrity of the DDR
pathway is required for full p21 activation following p400
knockdown. In contrast, the DDR pathway is not required for
full p21 activation by p53 in the absence of DNA damage (by the
Mdm2 inhibitor Nutlin-3, see Figure 4E). Taken together, these
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data demonstrate that regulation of the p21 promoter by p400
involves, at least in part, control of the DDR pathways upstream of
p53 transcriptional activity. Interestingly, such a mechanism is
consistent with our previous finding that p400 depletion does not
further activate p21 expression upon full induction of DDR
pathways through genotoxic treatments [12]. Note however that,
because ATM inhibition does not totally relieve p21 activation by
p400 knockdown, we cannot rule out the possibility that H2A.Z
incorporation participates in the repression of p21 expression by
p400 in U2OS cells.
p400 and the stress response
Here we identify Hspa1a (a gene encoding Hsp70 protein) and
FANCA as direct target genes of p400. Hspa1a and FANCA can
thus be added to known target genes of p400 which include some
E2F and c-myc target genes [36,37], the p21 cell cycle inhibitor
[11,12], estradiol-receptor target genes [13] and genes required
for pluripotency maintenance in ES cells [17]. Hsp70 plays a
major role in adaptation to various types of stresses [32]. p400,
through the regulation of Hsp70 expression, may also be
generally involved in stress response. Indeed, cells deficient for
both Hsp70 proteins are more susceptible to UV, osmotic stress,
ischemia, and heat [32]. It would be of particular interest to
investigate whether p400 itself is a target of stress-induced
pathways. Strikingly, cancer cells are subjected to various types of
stress and increased Hsp70 levels is a common feature of cancer
cells [38]. This increase is believed to help cancer cells to cope
with the various stresses they encounter, including therapy-
induced stress. Therefore, Hsp70 is an increasingly popular
potential therapeutic target. The results we present here suggest
that deregulation of p400 function may also favour cancer
progression and resistance to anticancer treatments through the
control of stress-response pathways. In agreement with such a
hypothesis, we recently showed that the siRNA-mediated
decrease of p400 levels favours the response to 5-fluorouracil of
colon cancer cells [15]. Our data highlight the importance of
studying p400 expression in human cancer and confirms that
p400 could be a promising therapeutic target.
Materials and Methods
Antibodies, plasmids, siRNAs, and Q-PCR primers
The p400 antibody was purchased from Abcam (Paris, France),
the anti-HDACs (which recognizes HDAC1, 2 and 3) from
Transduction Laboratories (Lexington, KY), the anti-HA from
Covance (Madison, WI), the anti-cH2AX from Upstate Biotech-
nologies (Millipore, Inc. Billerica, MA), the anti-GAPDH antibody
from Chemicon International, Inc (Temecula, CA), the anti-ATM
and the anti-phospho-ser15 p53 from Calbiochem (EMD
Chemicals, Inc. Darmstadt, Germany), the anti-phospho ATM
from Cell Signalling technology, Inc (Boston, MA), the anti-
H2A.Z and anti-FANCA from Abcam Inc (Cambridge, MA), the
anti-Hsp70 from StressGen (Ann Harbor, MI) and the anti-HA
(Y-11) and anti-b-actin (C-2) from Santa Cruz Biotechnology Inc
(Santa Cruz, CA). All secondary antibodies were purchased from
Amersham (Piscataway, NJ).
Hsp70 expressing plasmids and the corresponding empty vector
were kind gifts from Dr Claire Vourc’h. FANCA expressing
plasmid was a kind gift of Dr Filippo Rosselli (IGR, Villejuif,
France).
All siRNAs were purchased from Eurogentec. The control
siRNA does not recognize any human mRNA. The sequences of
the top strands of the various siRNAs were as follows:
Ctrl: CAUGUCAUGUGUCACAUCU-dTdT
p400-1: UGAAGAAGGUUCCCAAGAA-dTdT
p400-2: CAUCCACAUAUACAGGCUU-dTdT
p400-3: CGACACAUUGGAUACAGAA-dTdT
Hsp70: GCGAGAGGGUGUCAGCCAA-dTdT
ATM: GCCUCCAGGCAGAAAAAGA-dTdT
H2A.Z-1: GUAGUGGGUUUUGAUUGAG-dTdT
H2A.Z-2: AAAGGACAACAGAAGACUG-dTdT
FANCA: AAGCTGTCTTCCCTGTTAGAGTT-dTdT
The efficiency of siRNAs silencing was checked in each
experiments by reverse transcription followed by real time PCR
as described [12].
The following primer pairs were used to amplify cDNAs
following reverse transcription experiments (from 59 to 39):
p400: CTGCTGCGAAGAAGCTCGTT and CAATTCT-
TTCCCTCTCCTGC
ATM: ACCACACAGGAGAATATGGA and CTCTGCAG-
TAATGTATTACACA
p21: GTCAGAACCGGCTGGGGATG and TGAGCGAGG-
CACAAGGGTAC
p16: CTGCCCAACGCACCGAATAG and ACCACCAG-
CGTGTCCAGGAA
Hsp70: ACCAAGCAGACGCAGATCTTC and TCGGCCA-
AGGTGTTGGCGTCC
H2AZ: CCTTTTCTCTGCCTTGCTTG and CGGTGAGG-
TACTCCAGGATG
FANCA: CCAGCGTGATGTTATATCGG and CAAGGAA-
TCCCTCGTCCTAC
GAPDH: GAAGGTGAAGGTCGGAGTCA and GAAGA-
TGGTGATGGGATTTC
The following primer pairs were used to amplify promoters
following ChIP experiments (from 59 to 39):
P21: GTGGCTCTGATTGGCTTTCTG and CTGAAAA-
CAGGCAGCCCAAGG
Hspa1a: CCGACCCTTCCTGTCAATTA and TTCCTTG-
GACCAATCAGAGG
FANCA: GTCGTGGCCATGTTGGTC and CTTCAGGAC-
CAACCCCAGT
P0: GGCGACCTGGAAGTCCAACT and CCATCAGCAC-
CACAGCCTTC
Cell culture and transfections
Culture products were purchased from Invitrogen (Carlsbad,
CA). The colorectal carcinoma cell line HCT116, the human
normal lung fibroblasts IMR90 and the osteosarcoma cell line
U2OS were purchased from the ATCC collection. HCT116 and
U2OS cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) and IMR90 in Modified Eagle’s medium (MEM)
supplemented with antibiotics, 10% FCS and non-essential amino
acids (for IMR90). The construction of U2OS-HA-AsiSI-ER cells
is described in [25].
MEF cells were prepared from p400Mut/+ mice [19] using
E11.5 embryos. Dissected tissues were subjected to trypsinization
and dissociation using syringe before plating cells in Petri dishes
containing DMEM medium supplemented with 10% FCS,
Penicillin/Streptomycin cocktail and 10 mM b-mercaptoethanol.
MEF cells were then genotyped using RedExtract-N-Amp Tissue
PCR kit (Sigma, Saint Quentin Fallavier, France) and used in
experiment or maintained in culture for a maximum of five
passages.
H2O2, N-Acetyl-Cysteine (NAC) and Nutlin-3 were purchased
from Sigma and were added on cells at 10 mM, 10 mM and
20 mM, respectively. When needed, U2OS-HA-AsiSI-ER cells
were treated with 300 nM 4-OHTam for 4 h or 24 h. For
transfection, cells were electroporated with siRNAs or plasmids
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using an electroporation device (Amaxa AG, Ko¨ln, Germany),
according to manufacturer’s specifications.
Extract preparation and western blot analysis
Nuclear extracts or total cell lysates were prepared as
previously described [15]. 10 to 50 mg of proteins per lane were
separated by NuPAGE Novex 3-8% Tris-acetate gel (Invitrogen).
Proteins in the gel were transferred on a PVDF membrane.
Primary antibodies as well as peroxidase-conjugated secondary
antibodies were used according to standard western blot
procedure and peroxidase was detected by using the Lumi-
LightPLUS Western Blotting Substrate (Roche Diagnostics,
Meylan, France).
RNA extraction and reverse transcription
Total RNA was extracted using an RNeasy mini kit (QIAGEN).
2 mg of each purified RNA preparation was reverse-transcribed
and cDNAs were analysed by Q-PCR using specific primers (see
above).
DNA microarray analysis
Analysis on Affymetrix DNA microarrays (GeneChip Human
Gene 1.0 ST Array) was carried out using U2OS cells previously
transfected with siRNA targeting p400 (p400-1, p400-2; previously
described in [12]), or with control siRNA (C1, C2). p400-silencing
efficiency was checked by real time PCR and western blotting
(Figure S1A and S1B). 48 h after siRNA transfection, 100 ng of
total RNA for each condition was subjected to cleanup, reverse
transcription, amplification and labelling according to the
manufacturer’s instructions (GeneChip Whole Transcript Sense
Target Labelling Assay; Affymetrix).
Following quantification, raw data normalization and statistical
analysis was done using GeneSpring GX 10.0 analysis software
(Agilent technologies Inc, Santa Clara, CA). Briefly, after
normalization using the RMA algorithm, a T-test statistical
analysis was carried out to select genes whose expression levels
significantly change in knockdown p400 condition compared to
controls (p-value ,0.05). The Fold Change (FC) for each gene was
calculated for each siRNA p400 relative to each siRNA control.
Qualified genes are those found regulated with stringent criteria,
i.e. when their expression was modified more than 1.25 fold, in the
same way, in at least three out of four comparisons (p400-1 vs C1,
p400-2 vs C1, p400-1 vs C2 and p400-2 vs C2). Validation was
done by RT-QPCR using FANCA, Hsp70, TP53INP1 and p21
primers (Figure S3).
Gene co-occurrence analysis was done using GeneCoDis2
online software (http://genecodis.dacya.ucm.es/analysis/)
[39,40].
Real-time PCR analysis
Q-PCR analysis was performed on a CFX96 Real-time system
device (Biorad) using the platinium SYBR Green qPCR SuperMix
(Invitrogen), according to the manufacturer’s instructions, and
specific primers (see above). All experiments included a standard
curve and all samples were analyzed in triplicates.
Senescence Associated b-Gal assay (SA b-Gal assay)
Cells were submitted to the SA- b-Gal assay according to the
manufacturer’s instructions (96-well Cellular Senescence Assay
Kit, Cell Biolabs). Fluorescence was read with a fluorescence plate
reader (Fluoroskan Ascent, Thermolabsystems, Courtaboeuf,
France) at 365 nm (Excitation)/502 nm (Emission).
Cell cycle and apoptosis analysis using flow cytometry
For apoptosis analysis, cells were harvested and treated using an
AnnexinV-FITC/7-AAD kit (Beckman Coulter, Marseille,
France) according to the manufacturer’s instructions. Cells were
then analyzed by flow cytometry using FACScalibur apparatus
(Becton Dickinson).
For cell cycle analysis, cells were harvested, fixed with ethanol
and treated 30 min with Propidium iodide. Cells were then
analyzed by flow cytometry using FACScalibur and cell cycle
distribution was calculated using the ModFit LT V3.0 software
(Verity Software House, Inc. Topsham, ME).
DAPI staining, immunofluorescence, and quantification
Immunofluorescence of cells on coverslips, observations and
acquisition of native images were performed as previously
described [41]. Quantification of fluorescence levels was done on
approximately 100 cells/slide using home-developed macros in
ImageJ software (NIH, Bethesda, MA) to normalize background,
thresholds and signals.
Comet assay
The presence of DNA damages was assayed by alkaline comet
assay. U2OS cells were transfected with siRNA. After 48 h, cells
were harvested, mixed with low-melting-point agarose and layered
onto agarose-coated glass slides. Slides were maintained in the
dark at 4uC until electrophoresis. Slides were submerged in lysis
buffer for 1 h and incubated for 30 min in alkaline electrophoresis
buffer. After electrophoresis, slides were neutralized and stained
with ethidium bromide. Average Comet Tail Moment was scored
for 100 cells/slide by using the CometScore-v 1.5 software.
Measurement of intracellular ROS levels
Generation of ROS was studied by flow cytometry using
carboxy difluorodihydroFDA probe (Invitrogen). Cells seeded in 6-
well plates were washed with PBS and incubated with FDA probe
(5 mg/ml) in HBSS solution for 15 min at 37uC. Plates were then
placed on ice and trypsinized. Cells were resuspended in PBS and
immediately analysed by flow cytometry using FACScalibur
apparatus. The mean fluorescence intensity of 25,000 cells was
analyzed in each sample and corrected for autofluorescence from
unlabeled cells.
Chromatin Immunoprecipitation experiments
Experiments were performed as previously described in [12].
Briefly, a crosslink was done using formaldehyde 1% followed by
lysis of the cells, sonication of the DNA and immunoprecipitation
of protein/DNA complexes with specific antibodies or without
antibody as negative control. Crosslink was then reversed by
adding NaCl and DNA was purified with the GFX PCR kit
(Amersham) and analyzed by Q-PCR using specific primers (see
above).
Supporting Information
Figure S1 Typical experiments of siRNA-mediated silencing of
p400 and/or ATM (A), p400 (B), H2A.Z (C), Hsp70 (D), and
FANCA (E) in U2OS cells. U2OS cells were transfected as
described throughout the manuscript. 48 hours later, total cell
extracts or total RNA were prepared and analysed by western blot
using specific antibodies or by QPCR after reverse transcription,
respectively. The amounts of specific cDNA were divided by the
amount of GAPDH cDNA and calculated relative to 1 for cells
transfected by the control siRNA. A typical result is shown for
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each experiment and error bars stand for the variation between
the three Q-PCR replicates.
Found at: doi:10.1371/journal.pgen.1000983.s001 (2.19 MB PPT)
Figure S2 Complete list of modified genes upon p400 knock-
down, sorted by the mean of fold change.
Found at: doi:10.1371/journal.pgen.1000983.s002 (0.17 MB
XLS)
Figure S3 Validation, by RT-QPCR, of DNA microarray data
obtained after siRNA-mediated silencing of p400 in U2OS cells.
U2OS cells were transfected as described throughout the
manuscript. 48 hours later, total RNA were prepared and
analysed by QPCR after reverse transcription. The amounts of
specific cDNA were divided by the amount of GAPDH cDNA and
calculated relative to 1 for cells transfected by the control siRNA.
p400 knockdown efficiency (A) and results for two increased (B)
and two decreased (C) genes are shown. Error bars stand for the
variation between the three independent replicates.
Found at: doi:10.1371/journal.pgen.1000983.s003 (0.13 MB PPT)
Figure S4 Induction of ROS and p21 mRNA in U2OS by
H2O2 treatment. (A) U2OS cells were treated for 15 minutes
using 10 mM H2O2 in PBS. After washing with PBS, cells were
incubated with the FDA probe for 15 minutes, harvested and
analyzed by flow cytometry. Error bars stand for the variation
between the three independent replicates. (B) U2OS cells were
treated for 15 minutes using 5 mM H2O2 in PBS. After washing
with PBS, cells were incubated in serum-complemented DMEM
medium for 6 h at 37uC, harvested and total mRNA were
extracted. After reverse-transcription, QPCR using p21 primers
was performed. Error bars stand for the variation between the
three independent replicates.
Found at: doi:10.1371/journal.pgen.1000983.s004 (0.07 MB PPT)
Figure S5 Representative experiment of Comet tails analysis.
U2OS cells were transfected with siRNA. After 48 h, the presence
of DNA damages was assayed by alkaline comet assay. Tail
Moment was scored for 100 cells/slide. Cells with tail moments
greater than 5 were considered as DNA damage positive cells.
Found at: doi:10.1371/journal.pgen.1000983.s005 (0.07 MB PPT)
Figure S6 Effects of the p400-2 siRNA on DNA damage U2OS
cells were transfected by the indicated siRNA as described
throughout the manuscript. NAC was added, or not, 24 hours
later. 48 hours following transfection, cells were harvested and
subjected to a comet assay. The proportions of comet-positive cells
were calculated relative to 100 for cells transfected with the p400-2
siRNA in the absence of NAC.
Found at: doi:10.1371/journal.pgen.1000983.s006 (0.04 MB PPT)
Figure S7 Characterization of silencing efficiency of p400 and
ATM siRNAs in IMR90 and HCT116 cells IMR90 and HCT116
cells were transfected as described in the manuscript. siRNA-
mediated silencing was checked by western blotting and reverse
transcription followed by Q-PCR as described in Figure S1. A
typical result is shown and error bars stand for the variation
between the three Q-PCR replicates. Note that we were unable to
detect full length p400 in IMR90 cells because of a co-migrating
non-specific band.
Found at: doi:10.1371/journal.pgen.1000983.s007 (2.37 MB PPT)
Figure S8 Induction of ROS following H2A.Z knock-down.
U2OS cells were transfected using two siRNAs directed against
H2A.Z and ROS levels were measured 48 h later by flow
cytometry. Resultswere calculated relative to 1 for cells transfected
with control siRNA. The mean and SD from 3 independent
experiments are shown.
Found at: doi:10.1371/journal.pgen.1000983.s008 (0.07 MB PPT)
Figure S9 Hsp70 mRNA expression in MEFs following H2O2
treatment. MEFs derived from heterozygous embryos in which
one p400 allele was targeted (p400Mut/+)[19] or from control
wild type embryos (p400+/+) were treated or not, as indicated,
with 10 mM of H2O2 for 15 min. H2O2 was washed out and cells
were collected after the indicated time. Total RNA were prepared
and analysed by QPCR after reverse transcription. The amounts
of Hsp70 cDNA were divided by the amount of GAPDH cDNA
and calculated relative to 1 for untreated cells. The mean and SD
from 3 independent experiments are shown.
Found at: doi:10.1371/journal.pgen.1000983.s009 (0.07 MB PPT)
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